ISAL 2019 | Progress in AML & research at the University of Düsseldorf

Name: Progress in AML & research at the University of Düsseldorf
Uploaded: 2019-03-15T11:49:54.000Z
Duration: 1 min 27 s
Description: Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses progress in acute myeloid leukemia (AML) and the ongoing research into myeloid disorders at his lab. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Thomas Schröder • 15 Mar 2019

ISAL 2019

Acute Myeloid Leukemia Leukemia Enasidenib Midostaurin

Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses progress in acute myeloid leukemia (AML) and the ongoing research into myeloid disorders at his lab. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.